Powell, OH, United States of America

Michael R Grever

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 13(Granted Patents)


Location History:

  • Columbus, OH (US) (2005)
  • Powell, OH (US) (2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael R. Grever: Innovator in Cancer Treatment

Introduction

Michael R. Grever, based in Powell, OH, is a prominent inventor specializing in advancements in cancer treatment. With a significant focus on developing innovative therapies, Grever holds two patents that contribute to the field of oncology.

Latest Patents

Grever's most recent patents demonstrate his commitment to enhancing drug efficacy against cancer. His first patent involves "Compositions and methods for increasing drug efficacy in cancer." This method addresses the treatment of lymphoproliferative diseases by administering a combination therapy that includes at least one autophagy modulating agent and one CDK inhibitor agent. This strategy aims to enhance the cytotoxicity of the treatment, offering improved outcomes for patients suffering from these diseases.

Additionally, Grever holds a patent for "Treatment of patients with chronic lymphocytic leukemia." This invention outlines methods for treating patients with B-cell chronic lymphocytic leukemia (B-CLL) through the use of benzamide derivatives and specific antibodies. These methods focus on inducing apoptosis in B-CLL cells and increasing the expression of the 1D10 antigen, showcasing Grever's innovative approach to fighting leukemia.

Career Highlights

Michael R. Grever is affiliated with The Ohio State University, where he has contributed to cutting-edge research and development in cancer therapies. His work is characterized by a robust focus on combining various therapeutic agents to enhance treatment efficacy for patients with challenging diagnoses.

Collaborations

Throughout his career, Grever has collaborated with notable coworkers, including David M. Lucas and John C. Byrd. These partnerships have facilitated the sharing of expertise and resources, further enriching the research and innovations emerging from The Ohio State University.

Conclusion

Michael R. Grever exemplifies the spirit of innovation in the medical field, particularly in oncology. With his two patents aimed at improving cancer treatment, his contributions are paving the way for more effective therapies for patients battling life-threatening diseases. His ongoing work continues to inspire advancements and collaborations in the healthcare community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…